I am a Biotechnology Student in India...
Even if the older version exists, pharmaceutical companies have the power to enforce the new drug with their buying power...Pharma Companies gift a lot of doctors with various goodies to enforce the newer version - thus allowing company to make profits....
The Point to be noted here for Developers, Designers and Other Technologists - " Where Do you Draw the line ?"
Novartis might have made a slight modification to the structure of the drug - and thereby requesting patent for the new drug.. The new drug might be more effective or not, they would want to sell it at a premium...So where does one draw a line towards how much of a change is ok for the drug to be accepted as a new drug.. should the change be in effectiveness or structure or something else...
The same question applies to developers and designers - when someone uses their designs or code.. Where do you draw the line ?
The Point to be noted here for Developers, Designers and Other Technologists - " Where Do you Draw the line ?"
Novartis might have made a slight modification to the structure of the drug - and thereby requesting patent for the new drug.. The new drug might be more effective or not, they would want to sell it at a premium...So where does one draw a line towards how much of a change is ok for the drug to be accepted as a new drug.. should the change be in effectiveness or structure or something else...
The same question applies to developers and designers - when someone uses their designs or code.. Where do you draw the line ?